Stock listing
MDXG Stock Price, News, Filings & Events — Mimedx Group, Inc
Selected listing: MDXG · NASDAQ · USD · US
This page tracks Mimedx Group, Inc's MDXG:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MDXG:NASDAQ. MDXG:NASDAQ is the stock-level entry point for investors researching Mimedx Group, Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mimedx Group, Inc. (ticker: MDXG) is a public company based in the United States, specializing in regenerative medicine and advanced wound care products. With a market capitalization of approximately $625.6 million, Mimedx focuses on developing and commercializing innovative therapies to improve patient outcomes. The company's commitment to research and development positions it as a key player in the healthcare market.

- Ticker
- MDXG:NASDAQ
- Asset type
- Stock
- Market cap
- $631.1M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Mimedx Group, Inc MDXG:NASDAQ stock context
This page tracks Mimedx Group, Inc's MDXG:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MDXG:NASDAQ. MDXG:NASDAQ is the stock-level entry point for investors researching Mimedx Group, Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mimedx Group, Inc. (ticker: MDXG) is a public company based in the United States, specializing in regenerative medicine and advanced wound care products. With a market capitalization of approximately $625.6 million, Mimedx focuses on developing and commercializing innovative therapies to improve patient outcomes. The company's commitment to research and development positions it as a key player in the healthcare market.
Latest news from Mimedx Group, Inc
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
July 29, 2026
MIMEDX to Acquire Sanara MedTech
July 29, 2026
MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
July 20, 2026
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
May 21, 2026
MIMEDX Announces Launch of G4Derm® Plus
May 8, 2026
Mimedx Group, Inc earnings calls
MiMedx Group, Inc (MDXG) Q2 2026 Earnings Call
July 29, 2026 · Replay with transcript and chapters
MiMedx Group, Inc (MDXG) Q1 2026 Earnings Call
April 29, 2026 · Replay with transcript and chapters
MiMedx Group, Inc (MDXG) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
MiMedx Group, Inc (MDXG) Q3 2025 Earnings Call
October 29, 2025 · Replay with transcript and chapters
MiMedx Group, Inc (MDXG) Q2 2025 Earnings Call
July 30, 2025 · Replay with transcript and chapters
MiMedx Group, Inc (MDXG) Q1 2025 Earnings Call
April 30, 2025 · Replay with transcript and chapters
Research Mimedx Group, Inc
Mimedx Group, Inc investor report
Review AI stock analysis and investor report context for MDXG:NASDAQ.
Mimedx Group, Inc company profile
View the public company page for Mimedx Group, Inc on 6ix.
Mimedx Group, Inc news
Read company news and market updates connected to Mimedx Group, Inc.
Mimedx Group, Inc investor events
Find investor webinars, events, and replay context for Mimedx Group, Inc.